Observations placeholder

Treprostinil, Remodulin, Tyvaso

Identifier

015765

Type of Spiritual Experience

Hallucination

Number of hallucinations: 27

Background

A description of the experience

Treprostinil (marketed under the trade names Remodulin for infusion and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).

On Jan, 02, 2017 16,282 people reported to have side effects when taking Tyvaso.
Among them, 17 people (0.1%) have Hallucination

On Jan, 16, 2017 18,618 people reported to have side effects when taking Remodulin.
Among them, 10 people (0.05%) have Hallucination

 

On Dec, 26, 2016 16,282 people reported to have side effects when taking Tyvaso.
Among them, 1,433 people (8.8%) have Death

Time on Tyvaso when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 8.70% 47.83% 30.43% 13.04% 0.00% 0.00% 0.00%

On Dec, 27, 2016 18,618 people reported to have side effects when taking Remodulin.  Among them, 2,933 people (15.75%) have Death

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Commonsteps

References